High incidence of focal segmental glomerulosclerosis in nephrotic syndrome of childhood

T Srivastava, SD Simon, US Alon - Pediatric nephrology, 1999 - Springer
T Srivastava, SD Simon, US Alon
Pediatric nephrology, 1999Springer
In recent adult literature, there have been reports of an increasing incidence of focal
segmental glomerulosclerosis (FSGS) among patients with nephrotic syndrome. To examine
whether this observation is also relevant to the pediatric population we utilized our hospital
computerized database to analyze the data on children with primary nephrotic syndrome
seen first between the years 1984 and 1995. A questionnaire was also sent to all
metropolitan Kansas City pediatricians to identify possible patients outside the database …
Abstract
 In recent adult literature, there have been reports of an increasing incidence of focal segmental glomerulosclerosis (FSGS) among patients with nephrotic syndrome. To examine whether this observation is also relevant to the pediatric population we utilized our hospital computerized database to analyze the data on children with primary nephrotic syndrome seen first between the years 1984 and 1995. A questionnaire was also sent to all metropolitan Kansas City pediatricians to identify possible patients outside the database. The inclusion criteria were clinical nephrotic syndrome or proteinuria with a kidney biopsy. A total of 148 patients (group A) were identified; 86 of them from metropolitan Kansas City (group B). In group A the incidence of minimal change disease (MCD) and FSGS was 52.7% [95% confidence interval (CI) 44%–60%] and 23.0% (95% CI 16–29%), respectively and in group B 54.7% (95% CI 44%–65%) and 24.5% (95% CI 15%–33%), respectively. Those numbers were significantly different from the International Study of Kidney Disease in Children (ISKDC) reported incidence of 76.4% for MCD and 6.9% for FSGS. Similar to the ISKDC, in our population children over 6 years had a higher incidence of FSGS than younger children (32.8% vs. 16.7%, P=0.028). The annual incidence rate for nephrotic syndrome in group B was 2.2 cases/105 children per year, of which MCD comprised 1.22 cases/105 children per year and FSGS 0.5 cases/105 children per year. The annual incidence rates of both primary nephrotic syndrome (3.6) and FSGS (1.6) were significantly higher in African-Americans than Caucasians (1.8 and 0.3 cases/105 children per year, respectively). Our study indicates nearly no change in the annual incidence of pediatric primary nephrotic syndrome, but a higher incidence of FSGS with reciprocal decline in the incidence of MCD. The possibility of primary nephrotic syndrome being caused by a non-MCD entity is further raised among African-Americans and in children over 6 years. We conclude that our perception of primary nephrotic syndrome of childhood as a benign condition has to be carefully reexamined and a more-guarded prognostic approach adopted in our geographic area.
Springer